Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Adcendo raised $135m in Series B led by TCGX, w/ TPG Life, Orbimed, Venrock, Surveyor Capital, Logos Capital.

Adcendo raised $135m in Series B led by TCGX, w/ TPG Life, Orbimed, Venrock, Surveyor Capital, Logos Capital.

Biotech Health services

Denmark

Sweden

Spain

United Kingdom

Netherlands

United States

Israel

Investments

16 November 2024

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Adcendo (company)

Denmark

Biotech Health services

Total investments received (USD): 243.72M

Round value (USD): 135M

Round investors: HealthCap Novo A/S OrbiMed Advisors TCGX Ysios Capital Gilde Healthcare Surveyor Capital Pontifax Venture Capital TPG RA Capital Management Logos Capital Venrock Dawn Biopharma

Company: Adcendo

Industry: Biotech Health services

Related deals

Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare.

Biotech Health services

Denmark

Netherlands

United States

Investments 19 November 2025

Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

Biotech Health services

Denmark

Sweden

France

United States

Investments 16 October 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top